Hester Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 (Q2 FY26) to the NSE. The announcement is a routine compliance filing confirming timely submission of results. No specific financial figures, revenue numbers, or profit data are disclosed in this notice. Investors would need to refer to the actual results document for detailed performance metrics. This is a standard regulatory disclosure under SEBI listing requirements for listed companies.
Neutral filing — purely a procedural disclosure confirming results have been filed. Actual impact on shareholders depends on the numbers in the detailed results, which are not provided in this notice.